Drugs in Dev.
Musculoskeletal
Phase IV
Ireland 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Collagenase Clostridium Histolyticum
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Retreatment of Recurrent Dupuytren's Contractures
Details : Collagenase Clostridium Histolyticum is a Enzyme drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dupuytren Contracture.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
December 23, 2011
Lead Product(s) : Collagenase Clostridium Histolyticum
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
